Adaptive iterative dose reduction 3D (AIDR 3D) vs. filtered back projection: radiation dose reduction capabilities of wide volume and helical scanning techniques on area-detector CT in a chest phantom study.

BACKGROUND: Computed tomography (CT) has important roles for lung cancer screening, and therefore radiation dose reduction by using iterative reconstruction technique and scanning methods receive widespread attention. PURPOSE: To evaluate the effect of two reconstruction techniques (filtered back projection [FBP] and adaptive iterative dose reduction using three-dimensional processing [AIDR 3D]) and two acquisition techniques (wide-volume scan [WVS] and helical scan as 64-detector-row CT [64HS]) on the lung nodule identifications of using a chest phantom. MATERIAL AND METHODS: A chest CT phantom including lung nodules was scanned using WVS and 64HS at nine different tube currents (TCs; range, 270-10 mA). All CT datasets were reconstructed with AIDR 3D and FBP. Standard deviation (SD) measurements by region of interest placement and qualitative nodule identifications were statistically compared. 64HS and WVS were evaluated separately, and FBP images acquired with 270 mA was defined as the standard reference. RESULTS: SDs of all datasets with AIDR 3D showed no significant differences (P > 0.05) with standard reference. When comparing nodule identifications, area under the curve on WVS with AIDR 3D with TC <30 mA, on 64HS with AIDR 3D with TC <40 mA, and on reconstructions with FBP and each scan method with TC <60 mA was significantly lower than with standard reference (P < 0.05). With the same TC and reconstruction, SDs and nodule identifications of WVS were not significantly different from 64HS (P > 0.05). CONCLUSION: In term of SD of lung parenchyma and nodule identification, AIDR 3D can achieve more radiation dose reduction than FBP and there is no significant different between WVS and 64HS.

Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer patients.

PURPOSE: To prospectively compare the diagnostic capability of diffusion-weighted MR imaging obtained with fast advantage spin-echo sequence (FASE-DWI) and echo planar imaging sequence (EPI-DWI), short inversion time inversion recovery fast advanced spin-echo (STIR FASE) imaging and FDG PET/CT for N-stage assessment of non-small cell carcinoma (NSCLC) patients. MATERIALS AND METHODS: 95 consecutive operable NSCLC patients underwent STIR FASE imaging, FASE-DWI and EPI-DWI with a 3T system, integrated PET/CT, surgical treatment and pathological and follow-up examinations. Probability of lymph node metastasis was visually assessed using a 5-point visual scoring system. ROC analyses were used to compare diagnostic capability of all methods, while their diagnostic performance was also compared by means of McNemar's test on a per node basis. Finally, McNemar's test was also used for statistical comparison of accuracy of N-stage assessment. RESULTS: Areas under the curve (Azs) for STIR FASE imaging (Az=0.95) and FASE-DWI (Az=0.92) were significantly larger than those for EPI-DWI (Az=0.78; p<0.0001 for STIR FSE imaging and FASE-DWI) and PET/CT (Az=0.85; p=0.0001 for STIR FSE imaging, p=0.03 for FASE-DWI) on a per node basis analysis. Accuracy of N-stage assessment using STIR FASE imaging (84.2% [80/95]) and FASE-DWI (83.2% [79/95]) was significantly higher than that using EPI-DWI (76.8% [73/95]; p=0.02 for STIR FASE imaging, p=0.03 for FASE-DWI) and PET/CT (73.7% [70/95]; p=0.002 for STIR FSE imaging, p=0.004 for FASE-DWI). CONCLUSION: Qualitative N-stage assessments of NSCLC patients obtained with FASE-DWI as well as STIR FASE imaging are more sensitive and/or accurate than those obtained with EPI-DWI and FDG PET/CT.

3D ECG- and respiratory-gated non-contrast-enhanced (CE) perfusion MRI for postoperative lung function prediction in non-small-cell lung cancer patients: A comparison with thin-section quantitative computed tomography, dynamic CE-perfusion MRI, and perfusion scan.

PURPOSE: To compare predictive capabilities of non-contrast-enhanced (CE)- and dynamic CE-perfusion MRIs, thin-section multidetector computed tomography (CT) (MDCT), and perfusion scan for postoperative lung function in non-small cell lung cancer (NSCLC) patients. MATERIALS AND METHODS: Sixty consecutive pathologically diagnosed NSCLC patients were included and prospectively underwent thin-section MDCT, non-CE-, and dynamic CE-perfusion MRIs and perfusion scan, and had their pre- and postoperative forced expiratory volume in one second (FEV1 ) measured. Postoperative percent FEV1 (po%FEV1 ) was then predicted from the fractional lung volume determined on semiquantitatively assessed non-CE- and dynamic CE-perfusion MRIs, from the functional lung volumes determined on quantitative CT, from the number of segments observed on qualitative CT, and from uptakes detected on perfusion scans within total and resected lungs. Predicted po%FEV1 s were then correlated with actual po%FEV1 s, which were %FEV1 s measured postoperatively. The limits of agreement were also determined. RESULTS: All predicted po%FEV1 s showed significant correlation (0.73 ≤ r ≤ 0.93, P < 0.0001) and limits of agreement with actual po%FEV1 (non-CE-perfusion MRI: 0.3 ± 10.0%, dynamic CE-perfusion MRI: 1.0 ± 10.8%, perfusion scan: 2.2 ± 14.1%, quantitative CT: 1.2 ± 9.0%, qualitative CT: 1.5 ± 10.2%). CONCLUSION: Non-CE-perfusion MRI may be able to predict postoperative lung function more accurately than qualitatively assessed MDCT and perfusion scan.

Lung Cancer Assessment Using MR Imaging: An Update.

MR imaging has emerged as a major new research and diagnostic tool for various pulmonary diseases, especially lung cancer. State-of-the art thoracic MR imaging now has the potential to be used as a substitute for traditional imaging techniques and/or to play a complementary role in patient management. This article focuses on these recent advances in MR imaging for lung cancer imaging, especially for pulmonary nodule assessment, lung cancer staging, postoperative lung function prediction, and prediction and evaluation of therapeutic response and recurrence. The potential and limitations of routine clinical application of these advances are discussed and compared with those of other modalities.

Value of diffusion-weighted MR imaging using various parameters for assessment and characterization of solitary pulmonary nodules.

OBJECTIVES: To determine the appropriate parameters and evaluation method for characterizing solitary pulmonary nodules (SPNs) using quantitative parameters of diffusion-weighted imaging (DWI). METHODS: Thirty-two subjects with 36 SPNs underwent DWI with seven different b values (0, 50, 100, 150, 300, 500, and 1000s/mm(2)). Five quantitative parameters were obtained from the region of interest drawn over each SPN: apparent diffusion coefficients (ADCs), true diffusion coefficients (DCs), and perfusion fractions (PFs), and signal-intensity ratios between lesion and spinal cord from DWI (b values: 1000 [LSR1000] and 500 [LSR500)]). All quantitative parameters and the diagnostic capabilities were statistically compared. RESULTS: SPNs were diagnosed as follow: malignant (n=27) and benign (n=9). Parameter comparisons for malignant and benign showed both LSRs differed significantly (p<0.05). Applying feasible threshold values showed LSR500 specificity (88.9% [8/9]) and accuracy (77.8% [28/36]) were significantly higher than ADC, DC, and PF specificity and accuracy (p<0.05). LSR1000 accuracy (72.2% [26/36]) was significantly higher than DC accuracy, and its specificity (88.9% [8/9]) was significantly higher than ADC, DC, and PF specificities (p<0.05). CONCLUSIONS: For quantitative differentiation of SPNs, LSR evaluation was more useful and practical than ADC, DC, and PF, and choice of b values showed little impact for the differentiation.

Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.

PURPOSE: To prospectively compare the capabilities for TNM classification and assessment of clinical stage and operability among whole-body magnetic resonance (MR) imaging, coregistered positron emission tomographic (PET)/MR imaging with and without MR signal intensity (SI) assessment, and integrated fluorine 18 fluorodeoxyglucose (FDG) PET/computed tomography (CT) in non-small cell lung cancer (NSCLC) patients. MATERIALS AND METHODS: The institutional review board approved this study, and written informed consent was obtained from each patient. One hundred forty consecutive NSCLC patients (75 men, 65 women; mean age, 72 years) prospectively underwent whole-body MR imaging, FDG PET/CT, conventional radiologic examinations, and surgical, pathologic, and/or follow-up examinations. All factors and clinical stage and operability were then visually assessed. All PET/MR examinations were assessed with and without SI assessment. One examination used anatomic, metabolic, and relaxation-time information, and the other used only anatomic and metabolic information. κ statistics were used for assessment of all factors and clinical stages with final diagnoses. McNemar test was used to compare the capability of all methods to assess operability. RESULTS: Agreements of assessment of every factor (κ = 0.63-0.97) and clinical stage (κ = 0.65-0.90) were substantial or almost perfect. Regarding capability to assess operability, accuracy of whole-body MR imaging and PET/MR imaging with SI assessment (97.1% [136 of 140]) was significantly higher than that of MR/PET without SI assessment and integrated FDG PET/CT (85.0% [119 of 140]; P < .001). CONCLUSION: Accuracies of whole-body MR imaging and PET/MR imaging with SI assessment are superior to PET/MR without SI assessment and PET/CT for identification of TNM factor, clinical stage, and operability evaluation of NSCLC patients.

Solitary pulmonary nodules: Comparison of dynamic first-pass contrast-enhanced perfusion area-detector CT, dynamic first-pass contrast-enhanced MR imaging, and FDG PET/CT.

PURPOSE: To prospectively compare the capabilities of dynamic perfusion area-detector computed tomography (CT), dynamic magnetic resonance (MR) imaging, and positron emission tomography (PET) combined with CT (PET/CT) with use of fluorine 18 fluorodeoxyglucose (FDG) for the diagnosis of solitary pulmonary nodules. MATERIALS AND METHODS: The institutional review board approved this study, and written informed consent was obtained from each subject. A total of 198 consecutive patients with 218 nodules prospectively underwent dynamic perfusion area-detector CT, dynamic MR imaging, FDG PET/CT, and microbacterial and/or pathologic examinations. Nodules were classified into three groups: malignant nodules (n = 133) and benign nodules with low (n = 53) or high (n = 32) biologic activity. Total perfusion was determined with dual-input maximum slope models at area-detector CT, maximum and slope of enhancement ratio at MR imaging, and maximum standardized uptake value (SUVmax) at PET/CT. Next, all indexes for malignant and benign nodules were compared with the Tukey honest significant difference test. Then, receiver operating characteristic analysis was performed for each index. Finally, sensitivity, specificity, and accuracy were compared with the McNemar test. RESULTS: All indexes showed significant differences between malignant nodules and benign nodules with low biologic activity (P < .0001). The area under the receiver operating characteristic curve for total perfusion was significantly larger than that for other indexes (.0006 ≤ P ≤ .04). The specificity and accuracy of total perfusion were significantly higher than those of maximum relative enhancement ratio (specificity, P < .0001; accuracy, P < .0001), slope of enhancement ratio (specificity, P < .0001; accuracy, P < .0001), and SUVmax (specificity, P < .0001; accuracy, P < .0001). CONCLUSION: Dynamic perfusion area-detector CT is more specific and accurate than dynamic MR imaging and FDG PET/CT in the diagnosis of solitary pulmonary nodules in routine clinical practice.

Paired inspiratory/expiratory volumetric CT and deformable image registration for quantitative and qualitative evaluation of airflow limitation in smokers with or without copd.

RATIONALE AND OBJECTIVES: To evaluate paired inspiratory/expiratory computed tomography (CT; iCT/eCT) and deformable image registration for quantitative and qualitative assessment of airflow limitation in smokers. MATERIALS AND METHODS: Paired iCT/eCT images acquired from 35 smokers (30 men and 5 women) were coregistered and subtraction images (air trapping CT images [aCT]) generated. To evaluate emphysema quantitatively, the percentage of low-attenuation volume (LAV%) on iCT was calculated at -950 HU, as were mean and kurtosis on aCT for quantitative assessment of air trapping. Parametric response maps of emphysema (PRMe) and of functional small airways disease (PRMs) were also obtained. For qualitative evaluation of emphysema, low-attenuation areas on iCT were scored by consensus of two radiologists using Goddard classification. To assess air trapping qualitatively, the degree of air trapping on aCT was scored. For each quantitative and qualitative index, the Spearman rank correlation coefficient for forced expiratory flow in 1 second was calculated, and differences in correlation coefficients were statistically tested. RESULTS: The correlation coefficients for the indices were as follows: mean on aCT, 0.800; kurtosis on aCT, -0.726; LAV%, -0.472; PRMe, -0.570; PRMs, -0.565; addition of PRMe and PRMs, -0.653; emphysema score, -0.502; air trapping score, -0.793. The indices showing significant differences were as follows: mean on aCT and addition of PRMe and PRMs (P = 1.43 × 10(-8)); air trapping score and emphysema score (P = .0169). CONCLUSIONS: Air trapping images yielded more accurate quantitative and qualitative evaluation of airflow limitation than did LAV%, PRMe, PRMs, and Goddard classification.

A comparison of axial versus coronal image viewing in computer-aided detection of lung nodules on CT.

PURPOSE: To compare primarily viewing axial images (Axial mode) versus coronal reconstruction images (Coronal mode) in computer-aided detection (CAD) of lung nodules on multidetector computed tomography (CT) in terms of detection performance and reading time. MATERIALS AND METHODS: Sixty CT data sets from two institutions were collected prospectively. Ten observers (6 radiologists, 4 pulmonologists) with varying degrees of experience interpreted the data sets using CAD as a second reader (performing nodule detection first without then with aid). The data sets were interpreted twice, once each for Axial and Coronal modes, in two sessions held 4 weeks apart. Jackknife free-response receiver-operating characteristic analysis was used to compare detection performances in the two modes. RESULTS: Mean figure-of-merit values with and without aid were 0.717 and 0.684 in Axial mode and 0.702 and 0.671 in Coronal mode; use of CAD significantly increased the performance of observers in both modes (P < 0.01). Mean reading times for radiologists did not significantly differ between Axial (156 ± 74 s) and Coronal mode (164 ± 69 s; P = 0.08). Mean reading times for pulmonologists were significantly lower in Coronal (112 ± 53 s) than in Axial mode (130 ± 80 s; P < 0.01). CONCLUSION: There was no statistically significant difference between Axial and Coronal modes for lung nodule detection with CAD.

Emphysema quantification on low-dose CT using percentage of low-attenuation volume and size distribution of low-attenuation lung regions: effects of adaptive iterative dose reduction using 3D processing.

PURPOSE: To evaluate the effects of adaptive iterative dose reduction using 3D processing (AIDR 3D) for quantification of two measures of emphysema: percentage of low-attenuation volume (LAV%) and size distribution of low-attenuation lung regions. METHOD AND MATERIALS: Fifty-two patients who underwent standard-dose (SDCT) and low-dose CT (LDCT)were included. SDCT without AIDR 3D, LDCT without AIDR 3D, and LDCT with AIDR 3D were used for emphysema quantification. First, LAV% was computed at 10 thresholds from −990 to −900 HU. Next, at the same thresholds, linear regression on a log­log plot was used to compute the power law exponent (D)for the cumulative frequency-size distribution of low-attenuation lung regions. Bland­Altman analysis was used to assess whether AIDR 3D improved agreement between LDCT and SDCT for emphysema quantification of LAV% and D. RESULTS: The mean relative differences in LAV% between LDCT without AIDR 3D and SDCT were 3.73%­88.18% and between LDCT with AIDR 3D and SDCT were −6.61% to 0.406%. The mean relative differences in D between LDCT without AIDR 3D and SDCT were 8.22%­19.11% and between LDCT with AIDR3D and SDCT were 1.82%­4.79%. AIDR 3D improved agreement between LDCT and SDCT at thresholds from −930 to −990 HU for LAV% and at all thresholds for D. CONCLUSION: AIDR 3D improved the consistency between LDCT and SDCT for emphysema quantification of LAV% and D.

Asthma: comparison of dynamic oxygen-enhanced MR imaging and quantitative thin-section CT for evaluation of clinical treatment.

PURPOSE: To compare the use of dynamic oxygen-enhanced magnetic resonance (MR) imaging with the use of quantitatively assessed computed tomography (CT) for assessment of clinical stage and evaluation of pulmonary functional change due to treatment in patients with asthma. MATERIALS AND METHODS: The institutional review board of Kobe University Hospital approved this study, and written informed consent was obtained from each subject. Thirty consecutive patients with asthma (17 men and 13 women; age range, 27-78 years) underwent dynamic oxygen-enhanced MR imaging, multidetector CT, and assessment of forced expiratory volume in 1 second. All patients were classified as having one of four stages of asthma according to the guidelines of the National Asthma Education and Prevention Program. Relative enhancement ratio ( RER relative enhancement ratio ) and wash-in time maps were generated by means of pixel-by-pixel analyses. Regions of interest were placed on images of the lung in all sections, and all measurements were averaged to determine mean RER relative enhancement ratio and mean wash-in time for each subject. Percentage of airway wall area and mean lung density were determined at quantitative CT. For comparison of the modalities for assessment of clinical stage, indexes of subjects at all clinical stages were compared by means of the Tukey honestly significant difference test. Evaluation of pulmonary functional improvement was assessed by correlating improvement of each index with that of forced expiratory volume. RESULTS: Mean wash-in time was significantly different among patients with asthma of different clinical stages (P < .05), but significant differences between mean RER relative enhancement ratio and percentage of airway wall area were observed for a limited number of clinical stages (P < .05). Improvement of mean RER relative enhancement ratio (r = 0.63, P = .0002) and mean wash-in time (r = -0.75, P < .0001) was significantly correlated with forced expiratory volume. CONCLUSION: Dynamic oxygen-enhanced MR imaging has potential as a tool for assessment of clinical stage and evaluation of pulmonary functional change due to treatment in patients with asthma.

Airflow limitation in chronic obstructive pulmonary disease: ratio and difference of percentage of low-attenuation lung regions in paired inspiratory/expiratory computed tomography.

RATIONALE AND OBJECTIVES: The purpose of this study was to analyze the relationship between airflow limitation and two types of computed tomography (CT) measurements: expiratory/inspiratory (E/I) ratio and E/I difference of percentage of low-attenuation lung regions (LAA%). MATERIALS AND METHODS: Thirty patients who underwent inspiratory and expiratory CT scans were included in this study. The CT data were used to calculate the LAA% E/I ratio and E/I difference. Other types of CT measurements were also obtained, including the E/I ratio and E/I difference of lung volume, mean lung density, standard deviation, skewness, and kurtosis. LAA% was calculated at 20 thresholds (-990 to -800 HU). Pearson's correlation between the measurements and forced expiratory flow in 1 second was used to determine the efficacy of LAA% E/I ratio and E/I difference. P values of <5.88 × 10⁻5 were considered statistically significant with Bonferroni correction. RESULTS: The LAA% E/I ratio and E/I difference significantly correlated with forced expiratory flow in 1 second. The best correlation coefficient for the LAA% E/I ratio was -0.699 (P = 1.75 × 10⁻5) and for the LAA% E/I difference was -0.723 (P = 6.53 × 10⁻6). The best correlation coefficient for the LAA% E/I difference was stronger than that for the other types of CT measurements. CONCLUSIONS: The LAA% E/I ratio and E/I difference significantly correlated with airflow limitation in chronic obstructive pulmonary disease.

Iterative reconstruction technique vs filter back projection: utility for quantitative bronchial assessment on low-dose thin-section MDCT in patients with/without chronic obstructive pulmonary disease.

OBJECTIVES: The aim of this study was to evaluate the utility of the iterative reconstruction (IR) technique for quantitative bronchial assessment during low-dose computed tomography (CT) as a substitute for standard-dose CT in patients with/without chronic obstructive pulmonary disease. METHODS: Fifty patients (mean age, 69.2; mean % predicted FEV1, 79.4) underwent standard-dose CT (150mAs) and low-dose CT (25mAs). Except for tube current, the imaging parameters were identical for both protocols. Standard-dose CT was reconstructed using filtered back-projection (FBP), and low-dose CT was reconstructed using IR and FBP. For quantitative bronchial assessment, the wall area percentage (WA%) of the sub-segmental bronchi and the airway luminal volume percentage (LV%) from the main bronchus to the peripheral bronchi were acquired in each dataset. The correlation and agreement of WA% and LV% between standard-dose CT and both low-dose CTs were statistically evaluated. RESULTS: WA% and LV% between standard-dose CT and both low-dose CTs were significant correlated (r > 0.77, p < 0.00001); however, only the LV% agreement between SD-CT and low-dose CT reconstructed with IR was moderate (concordance correlation coefficient = 0.93); the other agreement was poor (concordance correlation coefficient <0.90). CONCLUSIONS: Quantitative bronchial assessment via low-dose CT has potential as a substitute for standard-dose CT by using IR and airway luminal volumetry techniques. KEY POINTS: • Quantitative bronchial assessment of COPD using low-dose CT is possible. • Airway luminal volumetry with iterative reconstruction is insusceptible to dose reduction. • Filtered back-projection is susceptible to the effect of dose reduction. • Wall area percentage assessment is easily influenced by dose reduction.

Emphysema quantification by combining percentage and size distribution of low-attenuation lung regions.

OBJECTIVE: The purpose of this study was to investigate efficacy of two types of emphysema quantification: percentage of low-attenuation lung regions (%LA); and size distribution of these regions. On a log-log plot, cumulative frequency-size distribution of low-attenuation lung regions can be fitted by a straight line whose slope (D) has been reported to reflect diffusing capacity. In this study, %LA and D were compared with pulmonary function test (PFT) parameters, especially with ratio of diffusing capacity of carbon monoxide to effective alveolar ventilation (i.e., DLCO/VA). MATERIALS AND METHODS: Thin-section unenhanced CT images were acquired from 30 patients (25 men, five women; mean [SD] age, 70.1 ± 12.1 years), of whom 25 had received diagnosis of COPD, and %LA and D were calculated at 20 thresholds, ranging from -995 to -900 HU. To determine utility of %LA and D, we used Pearson's correlation for emphysema quantification and PFT. Significance of the coefficients was determined with Bonferroni correction (p < 0.0025). Finally, the relationships between emphysema quantification and DLCO/VA were examined by linear models and Akaike information criterion (AIC). RESULTS: The correlation coefficients for %LA and DLCO/VA were statistically significant at all the thresholds (optimal coefficient, -0.761). The correlation coefficients for D and DLCO/VA were statistically significant at the thresholds from -945 to -900 HU (optimal coefficient, -0.646). AIC values showed that the most accurate prediction of DLCO/VA was obtained by the model incorporating both %LA and D. CONCLUSION: Both %LA and D showed significant correlation with DLCO/VA. Combining %LA and D resulted in more accurate evaluation of DLCO/VA than did using %LA or D alone.

Journal Club: Comparison of assessment of preoperative pulmonary vasculature in patients with non-small cell lung cancer by non-contrast- and 4D contrast-enhanced 3-T MR angiography and contrast-enhanced 64-MDCT.

OBJECTIVE: The purpose of this article is to prospectively and directly compare the capabilities of non-contrast-enhanced MR angiography (MRA), 4D contrast-enhanced MRA, and contrast-enhanced MDCT for assessing pulmonary vasculature in patients with non-small cell lung cancer (NSCLC) before surgical treatment. SUBJECTS AND METHODS: A total of 77 consecutive patients (41 men and 36 women; mean age, 71 years) with pathologically proven and clinically assessed stage I NSCLC underwent thin-section contrast-enhanced MDCT, non-contrast-enhanced and contrast-enhanced MRA, and surgical treatment. The capability for anomaly assessment of the three methods was independently evaluated by two reviewers using a 5-point visual scoring system, and final assessment for each patient was made by consensus of the two readers. Interobserver agreement for pulmonary arterial and venous assessment was evaluated with the kappa statistic. Then, sensitivity, specificity, and accuracy for the detection of anomalies were directly compared among the three methods by use of the McNemar test. RESULTS: Interobserver agreement for pulmonary artery and vein assessment was substantial or almost perfect (κ=0.72-0.86). For pulmonary arterial and venous variation assessment, there were no significant differences in sensitivity, specificity, and accuracy among non-contrast-enhanced MRA (pulmonary arteries: sensitivity, 77.1%; specificity, 97.4%; accuracy, 87.7%; pulmonary veins: sensitivity, 50%; specificity, 98.5%; accuracy, 93.2%), 4D contrast-enhanced MRA (pulmonary arteries: sensitivity, 77.1%; specificity, 97.4%; accuracy, 87.7%; pulmonary veins: sensitivity, 62.5%; specificity, 100.0%; accuracy, 95.9%), and thin-section contrast-enhanced MDCT (pulmonary arteries: sensitivity, 91.4%; specificity, 89.5%; accuracy, 90.4%; pulmonary veins: sensitivity, 50%; specificity, 100.0%; accuracy, 95.9%) (p>0.05). CONCLUSION: Pulmonary vascular assessment of patients with NSCLC before surgical resection by non-contrast-enhanced MRA can be considered equivalent to that by 4D contrast-enhanced MRA and contrast-enhanced MDCT.

Dynamic contrast-enhanced CT and MRI for pulmonary nodule assessment.

OBJECTIVE: The purpose of this article is to review advanced imaging of pulmonary nodules, including pathologic and pharmacokinetic background, conventional contrast-enhanced CT and MRI assessment, dynamic contrast-enhanced CT and MRI techniques, and dual-source and area-detector CT systems for pulmonary nodule evaluation. CONCLUSION: Clinicians need to understand the underlying principles and pathologic and pharmacokinetic backgrounds of contrast-enhanced CT and MRI to further improve diagnostic performance. With adjustments in image acquisition and postprocessing, contrast-enhanced CT and MRI, especially the dynamic versions, can have enhanced clinical application for pulmonary nodules and expanded clinical relevance for other thoracic diseases.

Pulmonary 3 T MRI with ultrashort TEs: influence of ultrashort echo time interval on pulmonary functional and clinical stage assessments of smokers.

PURPOSE: To assess the influence of ultrashort TE (UTE) intervals on pulmonary magnetic resonance imaging (MRI) with UTEs (UTE-MRI) for pulmonary functional loss assessment and clinical stage classification of smokers. MATERIALS AND METHODS: A total 60 consecutive smokers (43 men and 17 women; mean age 70 years) with and without COPD underwent thin-section multidetector row computed tomography (MDCT), UTE-MRI, and pulmonary functional measurements. For each smoker, UTE-MRI was performed with three different UTE intervals (UTE-MRI A: 0.5 msec, UTE-MRI B: 1.0 msec, UTE-MRI C: 1.5 msec). By using the GOLD guidelines, the subjects were classified as: "smokers without COPD," "mild COPD," "moderate COPD," and "severe or very severe COPD." Then the mean T2* value from each UTE-MRI and CT-based functional lung volume (FLV) were correlated with pulmonary function test. Finally, Fisher's PLSD test was used to evaluate differences in each index among the four clinical stages. RESULTS: Each index correlated significantly with pulmonary function test results (P < 0.05). CT-based FLV and mean T2* values obtained from UTE-MRI A and B showed significant differences among all groups except between "smokers without COPD" and "mild COPD" groups (P < 0.05). CONCLUSION: UTE-MRI has a potential for management of smokers and the UTE interval is suggested as an important parameter in this setting.

Oxygen-enhanced MRI for patients with connective tissue diseases: comparison with thin-section CT of capability for pulmonary functional and disease severity assessment.

PURPOSE: To prospectively and directly compare oxygen-enhanced (O2-enhanced) MRI with thin-section CT for pulmonary functional loss and disease severity assessment in connective tissue disease (CTD) patients with interstitial lung disease (ILD). MATERIALS AND METHODS: Thin-section CT, O2-enhanced MRI, pulmonary function test and serum KL-6 were administered to 36 CTD patients with ILD (23 men, 13 women; mean age: 63.9 years) and nine CTD patients without ILD (six men, and three women; mean age: 62.0 years). A relative-enhancement ratio (RER) map was generated from O2-enhanced MRI and mean relative enhancement ratio (MRER) for each subject was calculated from all ROI measurements. CT-assessed disease severity was evaluated with a visual scoring system from each of the thin-section CT data. MRER and CT-assessed disease severities of CTD patients with and without ILD were then statistically compared. To assess capability for pulmonary functional loss and disease severity assessment in CTD patients, correlations of MRER and CT-assessed disease severity with pulmonary functional parameters and serum KL-6 in all subjects were statistically determined. RESULTS: MRER and CT-assessed disease severity showed significant differences between CTD patients with (MRER: 0.15 ± 0.08, CT-assessed disease severity: 13.0 ± 7.4%) and without ILD (MRER: 0.25 ± 0.06, p=0.0011; CT-assessed disease severity: 1.6 ± 1.6%, p<0.0001). MRER and CT-assessed disease severity correlated significantly with pulmonary functional parameters and serum KL-6 in all subjects (0.61 ≤ r ≤ 0.79, p<0.05). CONCLUSION: O2-enhanced MRI was found to be as useful as thin-section CT for pulmonary functional loss and disease severity assessment of CTD patients with ILD.

Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients.

PURPOSE: The purpose of this study was to compare diagnostic capabilities for assessment of recurrence in non-small cell lung cancer (NSCLC) patients by contrast-enhanced whole-body MRI (CE-WB-MRI) with and without CE-Quick 3D and double RF fat suppression technique (DFS), FDG-PET/CT and conventional radiological examinations. MATERIALS AND METHODS: A total of 134 pathologically proven and completely resected NSCLC patients (78 males, 56 females; mean age: 72 years) underwent FDG-PET/CT, CE-WB-MRI with and without Quick 3D and DFS at 3T as well as conventional radiological examinations. The probability of recurrence was assessed with a 5-point scoring system on a per-patient basis, and final diagnosis was made by consensus between two readers. The capability for overall recurrence assessment by all the methods was compared by means of ROC analysis and their sensitivity, specificity and accuracy by means of McNemar's test. RESULTS: Although areas under the curve did not show any significant differences, specificity (100%) and accuracy (95.5%) of CE-WB-MRI with CE-Quick 3D and DFS were significantly higher than those of FDG-PET/CT (specificity: 93.6%, p=0.02; accuracy: 89.6%, p=0.01) and conventional radiological examinations (specificity: 92.7%, p=0.01; accuracy: 91.0%, p=0.03). In addition, specificity of CE-WB-MRI without CE-Quick 3D and DFS (100%) was significantly higher than that of FDG-PET/CT (p=0.02) and conventional radiological examinations (p=0.01). CONCLUSION: Specificity and accuracy of CE-WB-MRI with CE-Quick 3D and DFS for assessment of recurrence in NSCLC patients are at least as high as, or higher than those of others.

Comparison of quantitatively analyzed dynamic area-detector CT using various mathematic methods with FDG PET/CT in management of solitary pulmonary nodules.

OBJECTIVE: The objective of our study was to prospectively compare the capability of dynamic area-detector CT analyzed with different mathematic methods and PET/CT in the management of pulmonary nodules. SUBJECTS AND METHODS: Fifty-two consecutive patients with 96 pulmonary nodules underwent dynamic area-detector CT, PET/CT, and microbacterial or pathologic examinations. All nodules were classified into the following groups: malignant nodules (n = 57), benign nodules with low biologic activity (n = 15), and benign nodules with high biologic activity (n = 24). On dynamic area-detector CT, the total, pulmonary arterial, and systemic arterial perfusions were calculated using the dual-input maximum slope method; perfusion was calculated using the single-input maximum slope method; and extraction fraction and blood volume (BV) were calculated using the Patlak plot method. All indexes were statistically compared among the three nodule groups. Then, receiver operating characteristic analyses were used to compare the diagnostic capabilities of the maximum standardized uptake value (SUVmax) and each perfusion parameter having a significant difference between malignant and benign nodules. Finally, the diagnostic performances of the indexes were compared by means of the McNemar test. RESULTS: No adverse effects were observed in this study. All indexes except extraction fraction and BV, both of which were calculated using the Patlak plot method, showed significant differences among the three groups (p < 0.05). Areas under the curve of total perfusion calculated using the dual-input method, pulmonary arterial perfusion calculated using the dual-input method, and perfusion calculated using the single-input method were significantly larger than that of SUVmax (p < 0.05). The accuracy of total perfusion (83.3%) was significantly greater than the accuracy of the other indexes: pulmonary arterial perfusion (72.9%, p < 0.05), systemic arterial perfusion calculated using the dual-input method (69.8%, p < 0.05), perfusion (66.7%, p < 0.05), and SUVmax (60.4%, p < 0.05). CONCLUSION: Dynamic area-detector CT analyzed using the dual-input maximum slope method has better potential for the diagnosis of pulmonary nodules than dynamic area-detector CT analyzed using other methods and than PET/CT.